Deep Track Capital reported a 9.74% stake in MoonLake Immunotherapeutics MLTX · 7,999,025 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 9.74%
Last report: 6.46% · filed 25/11/12
Shares held: 7,999,025 sh
Class: Class A ordinary share, par value $0.0001 per share
Stock: MoonLake Immunotherapeutics MLTX
Holder: Deep Track Capital
Event date: 26/06/30
Filed: 26/08/14

9.74% stake · +3.3pp from the last report

Stake: 9.74%
Last report: 6.46%
Since last report: +3.3pp

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Deep Track Capital's other 5% stake reports

Deep Track Capital
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.83% stake
450,000 sh
5.83% stake
Filed 09/02
Deep Track Capital
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
7.45% stake
7,736,455 sh
7.45% stake
Filed 08/14
Deep Track Capital
5% stakeX4 Pharmaceuticals
5% stake
X4 Pharmaceuticals
XFOR
8.33% stake
8,040,894 sh
8.33% stake
Filed 08/14
Deep Track Capital
5% stakeViridian Therapeutics, Inc.\DE
5% stake
Viridian Therapeutics, Inc.\DE
VRDN
3.25% stake
3,592,740 sh
3.25% stake
Filed 08/14
Deep Track Capital
5% stakePersonalis
5% stake
Personalis
PSNL
3.82% stake
4,000,000 sh
3.82% stake
Filed 08/14